Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.420
-0.110 (-4.35%)
Nov 21, 2024, 1:24 PM EST - Market open
Sana Biotechnology Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
328
Market Cap
540.31M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna S.A. | 1.10B |
Organogenesis Holdings | 455.04M |
OrthoPediatrics | 189.67M |
SI-BONE | 157.04M |
Standard BioTools | 155.90M |
Surmodics | 126.08M |
IGM Biosciences | 2.92M |
SANA News
- 1 day ago - Sana Biotechnology: The Story Becomes Murkier - Seeking Alpha
- 13 days ago - Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 16 days ago - Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 - GlobeNewsWire
- 7 weeks ago - Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference - GlobeNewsWire
- 2 months ago - Sana Biotechnology to Present at September 2024 Investor Conferences - GlobeNewsWire
- 3 months ago - Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer - GlobeNewsWire
- 3 months ago - Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle - GeekWire
- 7 months ago - Sana Biotechnology to Present at May and June 2024 Investor Conferences - GlobeNewsWire